180 Life Sciences Corp. ATNF

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.05 (-4.17%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of 180 Life Sciences Corp. (ATNF)
    180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $1.18

    • Market Cap

      $3.75 Million

    • Price-Earnings Ratio

      0.15

    • Total Outstanding Shares

      3.18 Million Shares

    • Total Employees

      4

    • Dividend

      No dividend

    • IPO Date

      June 27, 2017

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      3000 el camino real, Palo alto, CA, 94306

    • Homepage

      https://www.180lifesciences.com

    Historical Stock Splits

    If you bought 380 shares of ATNF before December 19, 2022, you'd have 1 share today.
    Execution DateSplit Amount
    February 28, 20241-for-19 (Reverse Split)
    December 19, 20221-for-20 (Reverse Split)

    Cash Flow Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Net Cash Flow From Investing Activities$2.47 Million
    Net Cash Flow From Operating Activities$-2.69 Million
    Net Cash Flow From Investing Activities, Continuing$2.23 Million
    Net Cash Flow From Financing Activities, Continuing$462,994
    Net Cash Flow$240,674
    Net Cash Flow, Continuing$481,348

    Income Statement

    October 1, 2023 to September 30, 2024
    MetricValue
    Basic Average Shares$927,784
    Diluted Earnings Per Share$7.98
    Net Income/Loss Attributable To Noncontrolling Interest$0
    Net Income/Loss Attributable To Parent$-3.12 Million
    Net Income/Loss$-3.12 Million
    Operating Income/Loss$-6.37 Million

    Comprehensive Income

    October 1, 2023 to September 30, 2024
    MetricValue
    Other Comprehensive Income/Loss$-3.26 Million
    Comprehensive Income/Loss$-3.26 Million
    Comprehensive Income/Loss Attributable To Parent$-3.26 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    October 1, 2023 to September 30, 2024
    MetricValue
    Liabilities And Equity$10.47 Million
    Equity$3.73 Million
    Accounts Payable$2.09 Million
    Liabilities$6.74 Million
    Noncurrent Assets$9.24 Million
    Equity Attributable To Noncontrolling Interest$0

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ATNF from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.